demonstrated that KM8094, a humanized monoclonal antibody targeting SLC1A5, can inhibit cellular Gln uptake by binding to SLC1A5
The MHRA has issued warnings about such products purchased online or from unregulated sources
The authors found that semaglutide was associated with certain adverse events more often
Official Resources for Patients These official resources may help patients understand Medicare drug coverage and GLP-1 medication safety: Important Coverage Disclaimer Michigan Weight Loss Institute cannot guarantee Medicare coverage, medication approval, pricing, pharmacy availability, copay amount, or eligibility for the Medicare GLP-1 Bridge Program
Recurrent genital or urinary tract infections : Frequent infections may require treatment adjustment or additional preventive measures
When retatrutide is used alongside insulin or sulfonylureas (relevant in the context of type 2 diabetes management), there may be an increased risk of hypoglycaemia